NCT02851368View on ClinicalTrials.gov

Near Infrared Fluorescence Imaging With Indocyanine Green

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Solitary Pulmonary Nodules
Interventions
DEVICE

near infrared fluorescence imaging (NIFI)

The NIFI system will be evaluated for its ability to 1) visualize nodules and their margins 2) differentiate between benign and malignant nodules and 3) identify additional undiagnosed nodules after receiving an injection of indocyanine green 1 day prior to planned surgery.

DRUG

Indocyanine Green

Indocyanine Green will be administered intravenously 1 day prior to NIFI.

Trial Locations (1)

15232

Department of Cardiothoracic Surgery, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT02851368 - Near Infrared Fluorescence Imaging With Indocyanine Green | Biotech Hunter | Biotech Hunter